Latest News about GILD
Recent news which mentions GILD
2 Top Dividend Stocks That Are Yielding More Than 3%
January 05, 2022
From Motley Fool
23 dividend stocks that can pass this strict quality screen
January 04, 2022
From MarketWatch
3 Biotech Stocks That Could Double in 2022
January 03, 2022
From Motley Fool
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today?
December 29, 2021
From InvestorPlace
Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S.
December 28, 2021
From Benzinga
Got $5,000? Buy and Hold These 3 Value Stocks for Years
December 24, 2021
From Motley Fool
The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review
December 23, 2021
From Benzinga
Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19
December 23, 2021
Tickers
GILD
From Benzinga
FDA Slaps Clinical Hold On Gilead's Injectable Lenacapavir In HIV Trials
December 22, 2021
Tickers
GILD
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
From Benzinga
European Commission Expands Use Of Remdesivir In COVID-19 Patients Not On Supplemental Oxygen
December 21, 2021
Tickers
GILD
From Benzinga
From Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
December 14, 2021
Tickers
GILD
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
Why Arcus Biosciences Stock Vaulted Higher in November
December 09, 2021
From Motley Fool
Is Gilead Sciences Stock a Buy Now?
December 07, 2021
From Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
December SPAC Merger Calendar: Upcoming Votes, Stocks To Watch
December 05, 2021
From Benzinga
Got $1,000? Check Out These 3 Top Biotech Stocks
December 03, 2021
From Motley Fool
3 Reasons Pfizer Stock Will Crush the Broader Market in 2022
December 01, 2021
From Motley Fool
From MarketWatch
Why NRx Pharmaceuticals Stock Soared Today
November 29, 2021
From Motley Fool
Why Are NRx Pharma's Shares Soaring Premarket?
November 29, 2021
From Benzinga
3 Dividend Stocks That Are Dirt Cheap Right Now
November 25, 2021
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.